Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
967.5 GBX | -1.62% | +0.33% | -10.06% |
Apr. 11 | UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates | MT |
Apr. 11 | Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.06% | 10.66B | A- | ||
+11.59% | 128B | A- | ||
-2.20% | 8.55B | C | ||
+12.53% | 7.1B | C | ||
+23.01% | 5.06B | B+ | ||
+7.13% | 3.4B | C- | ||
-1.19% | 3.08B | B- | ||
-10.28% | 2.11B | - | - | |
-8.61% | 2.03B | - | ||
-27.27% | 1.69B | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SN. Stock
- Ratings Smith & Nephew Plc